医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集
▼×

医療情報

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE® (plecanatide) in China

バイオテクノロジーヘルスケアマネージド・ケア製薬　 TimeLine: Pharmaceutical Group for TRULANCE plecanatide Synergy Pharmaceuticals Announces License

2018年08月07日

0

China National Drug Administration Approves Gilead’s Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide), a Single Tablet Regimen for the Treatment of HIV-1 Infection

China National Drug Administration Approves Gilead’s Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide), a Single Tablet Regimen for the Treatment of HIV-1 Infection

AIDS バイオテクノロジーヘルスケア感染症病院臨床試験製薬　 TimeLine: China National Drug Administration Approves Emtricitabine and Tenofovir Alafenamide Single Tablet Regimen for the Treatment

2018年08月06日

0

Clinical Innovations通过在中国成立全资子公司布局加速全球增长战略

Clinical Innovations通过在中国成立全资子公司布局加速全球增长战略

ヘルスケア医療機器病院臨床試験　 TimeLine: Clinical Innovations通过在中国成立

2018年08月02日

0

Shionogi Announces FDA Approval of Mulpleta® (Lusutrombopag)

Shionogi Announces FDA Approval of Mulpleta® (Lusutrombopag)

ヘルスケアヘルス一般外科感染症病院臨床試験製薬　 TimeLine: Shionogi Announces FDA Approval of Mulpleta

2018年08月01日

0

Infraredx Announces Launch of Makoto™ Intravascular Imaging System and Dualpro™ IVUS+NIRS Catheter in Japan

Infraredx Announces Launch of Makoto™ Intravascular Imaging System and Dualpro™ IVUS+NIRS Catheter in Japan

その他ヘルスバイオテクノロジーヘルスケアヘルス一般医療機器心臓学病院　 TimeLine: and Dualpro Infraredx Announces Launch of Makoto Intravascular Imaging System IVUS+NIRS Catheter in Japan

2018年07月31日

0

Clinical Innovations Accelerates Global Growth Strategy with Establishment of CI Medical Instruments in China

Clinical Innovations Accelerates Global Growth Strategy with Establishment of CI Medical Instruments in China

ヘルスケア医療機器病院臨床試験　 TimeLine: Clinical Innovations Accelerates Global Growth Establishment of CI Medical Instruments in China

2018年07月30日

0

New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

New Phase 3 Data Show Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

バイオテクノロジーヘルスケアヘルス一般病院臨床試験製薬　 TimeLine: New Phase 3 Data Show Investigational Subcutaneous Vedolizumab Meets Primary Endpoint in Achieving Week 52 in Patients with Moderately

2018年07月19日

0

大腸手術を受ける患者における目標指向型輸液管理の一環としてのMasimo PVi®の有用性を検討する新研究

大腸手術を受ける患者における目標指向型輸液管理の一環としてのMasimo PVi®の有用性を検討する新研究

ヘルスケア医療機器外科病院臨床試験　 TimeLine: Masimo PVI

2018年07月17日

0

新研究调查Masimo PVi®在结直肠手术患者目标指导补液管理中的功用

新研究调查Masimo PVi®在结直肠手术患者目标指导补液管理中的功用

ヘルスケア医療機器外科病院臨床試験　 TimeLine: 新研究调查Masimo PVi

2018年07月17日

0

New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

New Study Investigates the Utility of Masimo PVi® as Part of Goal-Directed Fluid Management in Patients Undergoing Colorectal Surgery

ヘルスケア医療機器外科病院臨床試験　 TimeLine: as Part of Goal-Directed Fluid Management Colorectal Surgery New Study Investigates the Utility of Masimo

2018年07月16日

0